Dr. Antonio Palumbo | CureTalks
Dr. Antonio Palumbo (MD) received his medical degree from the University of Torino - Italy; served his residency in internal medicine and held a fellowship in hematology/oncology at the University of Torino. Before his current position as Chief of the Myeloma Unit of the Department of Oncology, Division of Hematology, University of Torino, Dr. Palumbo was Research Associate at the Wistar Institute, University of Pennsylvania. He specialized in hematology malignancies and medical oncology and has clinical and research interest in plasma cell dyscrasia. He is a member of Board of Directors of the International Myeloma Society (IMS), of the Advisory Board of the International Myeloma Foundation (IMF) and president of the European Myeloma Network Trial Group (EMNTG). Dr. Palumbo is also leading several multidisciplinary projects on the molecular biology and the pathogenesis of multiple myeloma, and on the development of biological markers to predict clinical outcome. He is the principal investigator of many national and international trials investigating the role of new drugs and second-generation novel agents for the treatment of young and elderly patients with multiple myeloma, both at diagnosis and at relapse. The results achieved by his team and him contributed to prolong survival of patients and to improve their quality of life.
One of the worlds best Myeloma doctors, Dr. Antonio Palumbo will be be with us on this show. Dr. Palumbo will be explaining…